As biologic modalities grow more complex and timelines compress, the operational relationship between contract development and manufacturing organizations (CDMOs) and their clients determines the program efficiency, outcome quality, and supply reliab... Read more
As life sciences companies scale biologics, advanced therapies, and personalized medicines, sustainability has moved from aspiration to operational imperative. From decarbonizing complex global supply chains to embedding environmental governance into... Read more
Under the leadership of Joel Latham, Incannex Healthcare is advancing a differentiated pipeline of cannabinoid- and psychedelic-based therapeutics targeting significant unmet needs in sleep disorders, inflammatory disease, and anxiety... Read more
Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) provides an update on operational activities and reports its consolidated results for the fourth quarter and 12 months ended 31 December 2025. The full report can b... Read more
Announces appointment of Claire M. Fraser, Ph.D., to its Board of Directors Forms a global life sciences and diagnostics leader focused on high-volume testing in regulated applications Announces formation of four divisions: Waters Analyti... Read more
Sharp Sterile Manufacturing has announced a $28 million expansion of its site in Lee, Massachusetts. The enhanced state-of-the-art facility will strengthen opportunities for highly skilled engineering and pharmaceutical manufacturing roles wi... Read more
As biologic modalities grow more complex and timelines compress, the operational relationship between contract development and manufacturing organizations (CDMOs) and their clients determines the program efficiency, outcome quality, and supply reliab... Read more
Rezon Bio announces that its Warsaw-Duchnice facility has received approval from the U.S. Food and Drug Administration (FDA) for the commercial manufacturing of a biosimilar. This milestone represents an important step in the continued development ... Read more
© 2026 Biopharma Boardroom. All Rights Reserved.
